CA2113547A1 - Derives puriniques - Google Patents
Derives puriniquesInfo
- Publication number
- CA2113547A1 CA2113547A1 CA002113547A CA2113547A CA2113547A1 CA 2113547 A1 CA2113547 A1 CA 2113547A1 CA 002113547 A CA002113547 A CA 002113547A CA 2113547 A CA2113547 A CA 2113547A CA 2113547 A1 CA2113547 A1 CA 2113547A1
- Authority
- CA
- Canada
- Prior art keywords
- adenosine
- chloro
- propyl
- phenoxy
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK92626A DK62692D0 (fr) | 1992-05-14 | 1992-05-14 | |
DK0626/92 | 1992-05-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2113547A1 true CA2113547A1 (fr) | 1993-11-25 |
Family
ID=8095717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002113547A Abandoned CA2113547A1 (fr) | 1992-05-14 | 1993-05-12 | Derives puriniques |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0603348A1 (fr) |
JP (1) | JPH06508855A (fr) |
AU (1) | AU671995B2 (fr) |
CA (1) | CA2113547A1 (fr) |
DK (1) | DK62692D0 (fr) |
FI (1) | FI940167A (fr) |
IL (1) | IL105673A (fr) |
NZ (1) | NZ252110A (fr) |
WO (1) | WO1993023418A1 (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK155292D0 (da) * | 1992-12-23 | 1992-12-23 | Novo Nordisk As | Kemiske forbindelser, deres fremstilling og anvendelse |
US5589467A (en) * | 1993-09-17 | 1996-12-31 | Novo Nordisk A/S | 2,5',N6-trisubstituted adenosine derivatives |
BR9507683A (pt) * | 1994-05-10 | 1997-09-23 | Sandoz Ag | Derivados de adenosina |
EP0704215A3 (fr) * | 1994-06-02 | 1998-04-01 | Takeda Chemical Industries, Ltd. | Inhibiteur de l'aumentation de la perméabilité vasculaire |
GB9421133D0 (en) * | 1994-10-20 | 1994-12-07 | Glaxo Group Ltd | Medicaments |
US6110902A (en) * | 1997-06-23 | 2000-08-29 | Moehler; Hanns | Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine |
US6803457B1 (en) | 1999-09-30 | 2004-10-12 | Pfizer, Inc. | Compounds for the treatment of ischemia |
CO5180581A1 (es) * | 1999-09-30 | 2002-07-30 | Pfizer Prod Inc | Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia |
AU2001260076A1 (en) * | 2000-05-15 | 2001-11-26 | Novo-Nordisk A/S | Compounds for treating disorders where a decreased level of plasma ffa is desired |
US7414036B2 (en) | 2002-01-25 | 2008-08-19 | Muscagen Limited | Compounds useful as A3 adenosine receptor agonists |
US20100048501A1 (en) | 2006-03-21 | 2010-02-25 | Heinrich-Heine-Universitat Dusseldorf | Phosphorylated A2A Receptor Agonists |
CZ2009298A3 (cs) * | 2009-05-14 | 2010-11-24 | Univerzita Palackého v Olomouci | Substituované 6-benzylaminopurin ribosidy, jejich použití a farmaceutický prípravek tyto slouceniny obsahující |
AU2011203897B2 (en) | 2010-01-11 | 2016-11-17 | Inotek Pharmaceuticals Corporation | Combination, kit and method of reducing intraocular pressure |
US8501708B2 (en) * | 2010-03-26 | 2013-08-06 | Inotek Pharmaceuticals Corporation | Adenosine compounds and their use thereof |
US8476247B2 (en) | 2010-03-26 | 2013-07-02 | Inotek Pharmaceuticals Corporation | Method of reducing intraocular pressure in humans |
LT2807178T (lt) | 2012-01-26 | 2017-08-25 | Inotek Pharmaceuticals Corporation | (2r,3s,4r,5r)-5-(6-(ciklopentilamino)-9h-purin-9-il)-3,4-dihidroksitetrahidrofuran-2-il) } metilnitrato bevandeniai polimorfai ir jų gavimo būdai |
WO2014152723A1 (fr) | 2013-03-15 | 2014-09-25 | Inotek Pharmaceuticals Corporation | Formulations ophtalmiques |
JP2015172077A (ja) * | 2015-06-24 | 2015-10-01 | 中国医学科学院葯物研究所 | N6−置換アデノシン誘導体とn6−置換アデニン誘導体の鎮静、催眠、抗うつ、抗痙攣、抗てんかん、抗パーキンソン病と認知証予防・治療の用途 |
GB2582361A (en) * | 2019-03-21 | 2020-09-23 | Univ Warwick | Adenosine receptor agonists |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL128629C (fr) * | 1966-05-07 | |||
DE1670077C3 (de) * | 1966-05-07 | 1975-04-24 | Boehringer Mannheim Gmbh, 6800 Mannheim | Adenosin-Derivate und Verfahren zu ihrer Herstellung |
NL6717061A (fr) * | 1966-12-21 | 1968-06-24 | ||
DE2052596A1 (de) * | 1970-10-27 | 1972-05-04 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neuartige Verwendung von N(6)-substituierten Adenosin-Derivaten |
DE3406533A1 (de) * | 1984-02-23 | 1985-08-29 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten |
EP0300145A3 (fr) * | 1984-04-18 | 1989-08-30 | Whitby Research Incorporated | Dérivés d'adénosine N-6-phényle substitué comme vaso-dilatateurs cardiaques |
US4791103A (en) * | 1985-02-08 | 1988-12-13 | Warner-Lambert Company | 2,N6 -disubstituted adenosines, derivatives and methods of use |
JPH0696534B2 (ja) * | 1986-04-25 | 1994-11-30 | ヘキストジヤパン株式会社 | 抗痴呆剤 |
GB8729994D0 (en) * | 1987-12-23 | 1988-02-03 | Glaxo Group Ltd | Chemical compounds |
HUT61567A (en) * | 1990-12-07 | 1993-01-28 | Sandoz Ag | Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate |
DK62592D0 (fr) * | 1992-05-14 | 1992-05-14 | Novo Nordisk As |
-
1992
- 1992-05-14 DK DK92626A patent/DK62692D0/da unknown
-
1993
- 1993-05-11 IL IL105673A patent/IL105673A/en not_active IP Right Cessation
- 1993-05-12 CA CA002113547A patent/CA2113547A1/fr not_active Abandoned
- 1993-05-12 JP JP5519787A patent/JPH06508855A/ja active Pending
- 1993-05-12 NZ NZ252110A patent/NZ252110A/en unknown
- 1993-05-12 WO PCT/DK1993/000158 patent/WO1993023418A1/fr not_active Application Discontinuation
- 1993-05-12 AU AU40612/93A patent/AU671995B2/en not_active Ceased
- 1993-05-12 EP EP93909822A patent/EP0603348A1/fr not_active Withdrawn
-
1994
- 1994-01-13 FI FI940167A patent/FI940167A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU671995B2 (en) | 1996-09-19 |
JPH06508855A (ja) | 1994-10-06 |
AU4061293A (en) | 1993-12-13 |
FI940167A (fi) | 1994-03-03 |
DK62692D0 (fr) | 1992-05-14 |
FI940167A0 (fi) | 1994-01-13 |
EP0603348A1 (fr) | 1994-06-29 |
IL105673A (en) | 1998-01-04 |
WO1993023418A1 (fr) | 1993-11-25 |
NZ252110A (en) | 1996-07-26 |
IL105673A0 (en) | 1993-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2113547A1 (fr) | Derives puriniques | |
KR100349385B1 (ko) | 2-티오크산틴으로부터 얻어진 3-치환 아데닌 | |
CA2414018C (fr) | Derives de 2-aminocarbonyl-9h-purine | |
SK4842002A3 (en) | Purine derivatives | |
WO1999024449A2 (fr) | Composes chimiques | |
CS203093B2 (en) | Method of preparing substituted purines | |
SK391891A3 (en) | Xanthine derivatives and pharmaceutical composition comprising same | |
EP0256692B1 (fr) | 6-Thioxanthines | |
AU657415B2 (en) | Novel adenosine derivatives | |
US5578582A (en) | Methods of treating ischemia with C2, N6 -disubstituted adenosine derivatives | |
AU4081493A (en) | 8-substituted anthines as phosphodiesterase inhibitors | |
JPH10508032A (ja) | アリールチオキサンチン類 | |
WO1999012927A1 (fr) | Acyclonucleosides de purine utilises comme agents antiviraux | |
US5672588A (en) | Purine derivatives | |
US6306847B1 (en) | Condensed purine derivatives | |
JP2005526106A (ja) | ニトロベンジルチオイノシンの新規同族体 | |
US5977119A (en) | Trisubstituted thioxanthines | |
AU740264C (en) | Antiviral agents | |
JPH03218378A (ja) | キサンチン誘導体 | |
EP1395267A2 (fr) | Compositions therapeutiques modulant la reponse immunitaire chez un mammifere et leur utilisation | |
JPH04128285A (ja) | キサンチン誘導体 | |
WO2005111053A2 (fr) | Compositions pharmaceutiques présentant une activité anti-inflammatoire |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 19990512 |